Skip to main content

Advertisement

Table 1 Patient and disease characteristics

From: Long-term functional outcome after laryngeal cancer treatment

Parameter n (%)
Total 477 (100%)
Male sex 428 (89.7%)
Median Age (range) 64 (36–92)
Tumor subsite
 Supraglottic 124 (26%)
 Glottic 281 (58.9%)
 Subglottic 13 (2.7%)
 Transglottic 59 (12.4%)
cT stage
 1a 185 (38.8%)
 1b 47 (9.9%)
 2 118 (24.7%)
 3 79 (16.6%)
 4a 47 (9.9%)
 4b 1 (0.2%)
cN stage
 0 388 (81.3%)
 1 24 (5%)
 2a 4 (0.8%)
 2b 31 (6.5%)
 2c 24 (5%)
 3 6 (1.3%)
Clinical UICC stage  
 I 226 (47.4%)
 II 97 (20.3%)
 III 65 (13.6%)
 IVA 82 (17.2%)
 IVB 7 (1.5%)
  1. UICC Union for International Cancer Control (7th edition)